CEACAM1 Is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Clear Cell Renal Cell Carcinoma

Table 2

Logistic regression analysis of the association between CEACAM1 expression and clinicopathological features in ccRCC patients.

Characteristics	Total ()	Odds ratio (OR)	value
T status (T3 and T4 vs. T1 and T2)	539	0.569 (0.397-0.813)	0.002
N status (N1 vs. N0)	257	0.490 (0.151-1.390)	0.198
M status (M1 vs. M0)	506	0.501 (0.300-0.820)	0.007
Age (>60 vs. ≤60)	539	1.151 (0.821-1.615)	0.413
Histologic grade (G3 and G4 vs. G1 and G2)	531	0.531 (0.376-0.749)	<0.001
Pathologic stage (stage III and stage IV vs. stage I and stage II)	536	0.555 (0.389-0.788)	0.001
Primary therapy outcome (PD and SD vs. CR and PR)	147	0.439 (0.144-1.227)	0.126
Gender (male vs. female)	539	0.467 (0.324-0.670)	<0.001
Laterality (right vs. left)	538	1.127 (0.803-1.582)	0.490

T: tumor size; N: lymph node; M: metastasis; PD: progressive disease; SD: stable disease; PR: partial response; CR: complete response.